Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Persistent Psychosis After a Single Ingestion of "Ecstasy" (MDMA).

Patel A, Moreland T, Haq F, Siddiqui F, Mikul M, Qadir H, Raza S.

Prim Care Companion CNS Disord. 2011;13(6). pii: PCC.11l01200. doi: 10.4088/PCC.11l01200. No abstract available.

2.

The Homeodomain Resource: 2003 update.

Banerjee-Basu S, Moreland T, Hsu BJ, Trout KL, Baxevanis AD.

Nucleic Acids Res. 2003 Jan 1;31(1):304-6.

3.

Test-retest reliability of the ulnar F-wave minimum latency versus ulnar distal motor latency in healthy adults.

McNulty VB, McBride KD, Moreland TA, Allison SC, Moore JH, Ernst GP.

Electromyogr Clin Neurophysiol. 2001 Sep;41(6):323-8.

PMID:
11680855
4.
5.

Clopidogrel bioavailability: absence of influence of food or antacids.

McEwen J, Strauch G, Perles P, Pritchard G, Moreland TE, Necciari J, Dickinson JP.

Semin Thromb Hemost. 1999;25 Suppl 2:47-50.

PMID:
10440423
6.

[A relative bioavailability study of 2 oral formulations of omeprazole after their administration in repeated doses to healthy volunteers].

Richards JP, Gimeno M, Moreland TA, McEwen J.

Gastroenterol Hepatol. 1999 Apr;22(4):171-5. Spanish.

PMID:
10349786
8.

Raised plasma levels of atrial natriuretic factor in cardiac allograft recipients: evidence of increased cardiac secretion and decreased renal clearance.

Lang CC, Moreland T, Choy AM, Pringle TH, McNeill GP, Struthers AD.

Eur J Clin Pharmacol. 1995;48(6):429-34.

PMID:
8582459
9.

Ethanol kinetics: extent of error in back extrapolation procedures.

al-Lanqawi Y, Moreland TA, McEwen J, Halliday F, Durnin CJ, Stevenson IH.

Br J Clin Pharmacol. 1992 Oct;34(4):316-21.

10.

Pharmacokinetic consequences of product stereoselectivity in the metabolism of nafimidone: estimation of fraction metabolized.

Kerr BM, Boddy AV, Moreland TA, Levy RH.

J Pharm Sci. 1991 Aug;80(8):812-4. No abstract available.

PMID:
1791547
11.

Relationship between cefpirome clearance, serum creatinine, weight and age in patients treated for infection.

Wilcox MH, Pithie A, Smith G, Moreland TA, Davey PG, Finch RG.

J Antimicrob Chemother. 1991 Aug;28(2):291-9.

PMID:
1778859
12.

Bioavailability of cefuroxime axetil: comparison of standard and abbreviated methods.

Lang CC, Moreland TA, Davey PG.

J Antimicrob Chemother. 1990 Apr;25(4):645-50.

PMID:
2351625
13.

Multiple dose comparison of a whole 240 mg verapamil sustained-release tablet with two half tablets.

Moreland TA, McMurdo ME, McEwen J.

Biopharm Drug Dispos. 1989 May-Jun;10(3):311-9.

PMID:
2720134
14.

Pharmacokinetics, efficacy and adverse effects of sublingual salbutamol in patients with asthma.

Lipworth BJ, Clark RA, Dhillon DP, Moreland TA, Struthers AD, Clark GA, McDevitt DG.

Eur J Clin Pharmacol. 1989;37(6):567-71.

PMID:
2693116
15.

Sustained-release verapamil: multiple-dose pharmacokinetic comparison of 120-mg and 240-mg tablets and the effect of halving a 240-mg tablet.

McEwen J, Durnin C, McMurdo ME, Moreland TA.

J Cardiovasc Pharmacol. 1989;13 Suppl 4:S57-9.

PMID:
2475689
16.

Loss of antibiotic activity caused by photodegradation: in vivo studies.

Ferguson J, Phillips G, McEwan J, Moreland T, Johnson BE.

Br J Dermatol. 1988 Oct;119(4):550-1. No abstract available.

PMID:
3191022
17.
18.

The effects of once-daily dosing with ranitidine and cimetidine on theophylline pharmacokinetics.

McEwen J, McMurdo ME, Moreland TA.

Eur J Drug Metab Pharmacokinet. 1988 Jul-Sep;13(3):201-5.

PMID:
3240766
19.

A comparison of digoxin, diltiazem and their combination in the treatment of atrial fibrillation.

Lewis RV, Laing E, Moreland TA, Service E, McDevitt DG.

Eur Heart J. 1988 Mar;9(3):279-83.

PMID:
3289931
20.

Ciprofloxacin in plasma and peritoneal dialysate after oral therapy in patients on continuous ambulatory peritoneal dialysis.

Fleming LW, Moreland TA, Scott AC, Stewart WK, White LO.

J Antimicrob Chemother. 1987 Apr;19(4):493-503.

PMID:
3583969
21.

A comparison of verapamil and digoxin in the treatment of atrial fibrillation.

Lewis R, Lakhani M, Moreland TA, McDevitt DG.

Eur Heart J. 1987 Feb;8(2):148-53.

PMID:
3552680
22.

The metabolic fate of stiripentol in man.

Moreland TA, Astoin J, Lepage F, Tombret F, Levy RH, Baillie TA.

Drug Metab Dispos. 1986 Nov-Dec;14(6):654-62.

PMID:
2877822
23.

Prevention of the retained fetal membrane syndrome (retained placenta) during induced calving in dairy cattle.

Gross TS, Williams WF, Moreland TW.

Theriogenology. 1986 Sep;26(3):365-70.

PMID:
16726202
24.

Ciprofloxacin and antacids.

Fleming LW, Moreland TA, Stewart WK, Scott AC.

Lancet. 1986 Aug 2;2(8501):294. No abstract available.

PMID:
2874321
25.

Fibronectin in polyethylene glycol precipitates: evidence for a role in immune complexes.

Coppock JS, Scott DL, Carter SD, Moreland TM, Robinson MW.

Rheumatol Int. 1986;6(2):79-83.

PMID:
3764306
26.

Stiripentol kinetics in epilepsy: nonlinearity and interactions.

Levy RH, Loiseau P, Guyot M, Blehaut HM, Tor J, Moreland TA.

Clin Pharmacol Ther. 1984 Nov;36(5):661-9.

PMID:
6488687
27.

Michaelis-Menten kinetics of stiripentol in normal humans.

Levy RH, Loiseau P, Guyot M, Blehaut HM, Tor J, Moreland TA.

Epilepsia. 1984 Aug;25(4):486-91.

PMID:
6745219
28.

Carbamazepine/valproic acid interaction in man and rhesus monkey.

Levy RH, Moreland TA, Morselli PL, Guyot M, Brachet-Liermain A, Loiseau P.

Epilepsia. 1984 Jun;25(3):338-45.

PMID:
6426944
29.

Clinical pharmacokinetics of sodium valproate, carbamazepine and phenytoin. Level-dose ration and interactions.

Levy RH, Moreland TA.

Schweiz Rundsch Med Prax. 1984 Feb 7;73(6):159-63. Review. No abstract available.

PMID:
6424205
30.

Rationale for monitoring free drug levels.

Levy RH, Moreland TA.

Clin Pharmacokinet. 1984 Jan;9 Suppl 1:1-9.

PMID:
6705421
31.

No effect of food intake on clobazam absorption.

Cenraud B, Guyot M, Levy RH, Brachet-Liermain A, Morselli PL, Moreland TA, Loiseau P.

Br J Clin Pharmacol. 1983 Dec;16(6):728-30.

32.

Central core degeneration after tenotomy in soleus muscles of hyperthyroid rats.

Hall-Craggs EC, Max SR, Wines MM, Moreland TM, Hebel JR.

Exp Neurol. 1983 Sep;81(3):722-32.

PMID:
6884481
33.

The influence of dose-delivery time interval on neonatal plasma pethidine levels.

Moreland TA, Brice JE, Mohamdee O, Walker CH.

Acta Obstet Gynecol Scand. 1983;62(6):549-53.

PMID:
6670461
35.

The effect of fever on antipyrine metabolism in children.

Forsyth JS, Moreland TA, Rylance GW.

Br J Clin Pharmacol. 1982 Jun;13(6):811-5.

36.

Saliva carbamazepine levels in children before and during multiple dosing.

Moreland TA, Priestman DA, Rylance GW.

Br J Clin Pharmacol. 1982 May;13(5):647-51.

37.

Liver volume estimation using ultrasound scanning.

Rylance GW, Moreland TA, Cowan MD, Clark DC.

Arch Dis Child. 1982 Apr;57(4):283-6. No abstract available.

38.

Saliva carbamazepine and phenytoin level monitoring.

Rylance GW, Moreland TA.

Arch Dis Child. 1981 Aug;56(8):637-40.

39.

Naloxone pharmacokinetics in the newborn.

Moreland TA, Brice JE, Walker CH, Parija AC.

Br J Clin Pharmacol. 1980 Jun;9(6):609-12.

40.

Drug level monitoring in paediatric practice.

Rylance GW, Moreland TA.

Arch Dis Child. 1980 Feb;55(2):89-98. Review. No abstract available.

41.

Plasma naloxone levels in the newborn after intravenous and intramuscular administration [proceedings].

Brice JE, Moreland TA, Parija AC, Walker CH.

Br J Clin Pharmacol. 1979 Oct;8(4):412P-413P. No abstract available.

42.

Carbamazepine dose-frequency requirement in children.

Rylance GW, Moreland TA, Butcher GM.

Arch Dis Child. 1979 Jun;54(6):454-8.

43.

Effects of pethidine and its antagonists on the newborn.

Brice JE, Moreland TA, Walker CH.

Arch Dis Child. 1979 May;54(5):356-61.

44.

Patterns of drug prescribing for children in hospital.

Moreland TA, Rylance GW, Christopher LJ, Stevenson IH.

Eur J Clin Pharmacol. 1978 Nov 9;14(1):39-46.

PMID:
729605
45.

Carbamazepine for childhood seizures.

Rylance GW, Moreland TA.

Dev Med Child Neurol. 1978 Aug;20(4):528-31. No abstract available.

PMID:
689317
46.

Saliva carbamazepine levels in children.

Rylance GW, Butcher GM, Moreland T.

Br Med J. 1977 Dec 3;2(6100):1481. No abstract available.

47.

Age as a determinant of sensitivity to warfarin.

Shepherd AM, Hewick DS, Moreland TA, Stevenson IH.

Br J Clin Pharmacol. 1977 Jun;4(3):315-20.

48.

Studies on a ketone reductase in human and rat liver and kidney soluble fraction using warfarin as a substrate.

Moreland TA, Hewick DS.

Biochem Pharmacol. 1975 Nov 1;24(21):1953-7. No abstract available.

PMID:
1212245
49.

Level of dietary protein and toxicity of tannic acid in young turkeys.

Moreland TA, Topps JH, Michie W.

Proc Nutr Soc. 1975 May;34(1):2A. No abstract available.

PMID:
1144397
50.

An NADPH dependent warfarin reductase in human and rat liver and kidney soluble fraction.

Hewick DS, Moreland TA.

Br J Pharmacol. 1975 Mar;53(3):441P. No abstract available.

Supplemental Content

Loading ...
Support Center